1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus cabozantinib (N+C) versus sunitinib (S) for advanced renal cell carcinoma (aRCC): Outcomes by baseline disease characteristics in the phase 3 CheckMate 9ER trial
    Meeting Abstract

    Apolo, A. B.; Powles, T.; Burotto, M.; Bourlon, M. T.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; Suarez, C.; Porta, C.; Barrios, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Hearing loss after cisplatin-based chemotherapy: Patient-reported outcomes versus audiometric assessments
    Meeting Abstract

    Ardeshirrouhanifard, S.; Fosså, S.; Huddart, R. A.; Monahan, P. O.; Fung, C.; Song, Y.; Dolan, M. E.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Enfortumab vedotin in cisplatin-ineligible patients with locally advanced or metastatic urothelial cancer who received prior PD-1/PD-L1 inhibitors: An updated analysis of EV-201 Cohort 2
    Meeting Abstract

    McGregor, B. A.; Balar, A. V.; Rosenberg, J. E.; Van Der Heijden, M. S.; Park, S. H.; Lee, J. L.; Kojima, T.; Harrison, M. R.; Heath, E. I.; Stein, M. N.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • CANTATA: Primary analysis of a global, randomized, placebo (Pbo)-controlled, double-blind trial of telaglenastat (CB-839) + cabozantinib versus Pbo + cabozantinib in advanced/metastatic renal cell carcinoma (mRCC) patients (pts) who progressed on immune checkpoint inhibitor (ICI) or anti-angiogenic therapies
    Meeting Abstract

    Tannir, N. M.; Agarwal, N.; Porta, C.; Lawrence, N. J.; Motzer, R. J.; Lee, R. J.; Jain, R. K.; Davis, N. B.; Appleman, L. J.; Goodman, O. B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PSMA-targeted imaging with (18)F-DCFPyL-PET/CT in patients (pts) withbiochemically recurrent prostate cancer (PCa): A phase 3 study (CONDOR)-A subanalysis of correct localization rate (CLR) and positive predictive value (PPV) by standard of truth
    Meeting Abstract

    Pouliot, F.; Gorin, M. A.; Rowe, S. P.; Saperstein, L.; Josephson, D.; Carroll, P. R.; Wong, J. Y. C.; Pantel, A. R.; Cho, S. Y.; Gage, K. L.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus and peripheral sensory neuropathy
    Meeting Abstract

    Zhang, X.; Trendowski, M. R.; Wilkinson, E.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; Huddart, R. A.; Martin, N. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Analysis of the CLEAR study in patients (pts) with advanced renal cell carcinoma (RCC): Depth of response and efficacy for selected subgroups in the lenvatinib (LEN) + pembrolizumab (PEMBRO) and sunitinib (SUN) treatment arms
    Meeting Abstract

    Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Gordoa, T. A.; Eto, M.; Hutson, T. E.; Motzer, R. J.; Winquist, E.; Maroto-Rey, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels
    Meeting Abstract

    Shuey, M.; Faucon, A.; Trendowski, M. R.; Ratain, M. J.; Dinh, P. C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Study EV-103: Update on durability results and long term outcome of enfortumab vedotin + pembrolizumab in first line locally advanced or metastatic urothelial carcinoma (la/mUC)
    Meeting Abstract

    Friedlander, T. W.; Milowsky, M. I.; Bilen, M. A.; Srinivas, S.; McKay, R. R.; Flaig, T. W.; Hoimes, C. J.; Balar, A. V.; Henry, E.; Petrylak, D. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Factors associated with use of medications for anxiety and depression in testicular cancer survivors after cisplatin-based chemotherapy
    Meeting Abstract

    Ardeshirrouhanifard, S.; Dinh, P. C.; Monahan, P. O.; Fosså, S.; Huddart, R. A.; Fung, C.; Song, Y.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save